Part 3/13:
Furthermore, unlike the early stages of COVID-19—when no vaccine existed—there is already a vaccine developed for H5N1 bird flu. The Biden administration has contracted manufacturers to produce nearly 5 million doses, yet bureaucratic red tape appears to be hampering their deployment. Experts argue that prompt authorization and distribution of this vaccine could be a vital measure to protect vulnerable populations, including farm workers. However, political factors and potential interference from anti-vaccine entities threaten to delay or withhold approval, especially with a new administration in office.